The primary focus of this presentation will be new and emerging drug trends across the country. The overall number of substances being abused today has noticeably increased over the past few years. Much of this increase can be attributed to the influx of synthetic drugs as well as newer forms of some existing drugs. Substances known as “Wax”, “Dabs”, “N-Bomb”, “Molly” and others are relatively new to the drug scene and continue to increase in popularity. These substances, along with existing substances known as “G”, “Ice”, “Boy” and “Tar” are causing an avalanche of problems for parents, law enforcement, educators, judges, medical professionals, correction officers, child welfare workers, prosecutors and others. Attendees will be provided information on synthetic cannabinoids, synthetic cathinones and synthetic hallucinogens. Specific drug trends, legislation and drug slang terms from across the country will also be discussed.
In addition, attendees will receive information on other trends (including Butane Hash Oil and THC extraction) as well as the resurgence of drugs such as Heroin, GHB and other illicit substances. These drug trends present an increasing threat to children across the country. This presentation will include information on the abuse of these substances by juveniles themselves along with the potential for more incapacitated caregivers, which could result in more ignored, abused, and abandoned children. The education of professionals from a variety of disciplines about these ever-changing drug trends will increase the likelihood that the indicators of abuse of new substances can be identified earlier, thus diminishing the threat to children.
Learning Objectives:
• At the conclusion of this presentation, attendees will have an increased awareness of the growing trend of synthetic drug abuse along with other relevant, current national drug trends
• Attendees will be provided specific information about Butane Hash Oil (BHO), synthetic cannabinoids, synthetic cathinones and synthetic hallucinogens. This will include information on the manufacturing process as well as specific photographic and video examples to assist attendees with the identification of these new substances
• This presentation will increase awareness of these emerging drug trends, causing an increased likelihood of early intervention by professionals in situations affecting children of all ages
Please check the box next to the following questions if the answer is 'yes'.
Please enter the applicable Event Date if there is an Event associated with this TTA.
When entering an Event Date, the Time is also required.
If the TTA is targeted to a particular audience or location, please complete the questions below.
Milestones are an element, activity, work product, or key task associated with completing the TTA (e.g. kick-off meeting, collect data from stake holders, deliver initial data analysis).
Please complete the fields below, if applicable, to create a milestone for this TTA.
Please respond to the Performance Metrics below. The Performance Metrics questions are based on the TTA Type indicated in the General Information section of the TTA.
Please submit a signed letter of support from your agency’s executive or other senior staff member. The letter can be emailed to or uploaded with this request. The letter should be submitted on official letterhead and include the following information:
- General information regarding the request for TTA services, i.e., the who, what, where, when, and why.
- The organizational and/or community needs specific to the request for TTA services.
- The benefits or anticipated outcomes from the receipt of TTA services.
By submitting this application to BJA NTTAC, I understand that upon approval of this application for TTA, the requestor agrees to keep BJA NTTAC informed of any circumstances that may impact the delivery of the TTA, including changes in the date of the event, event cancellation, or difficulties communicating with the assigned TTA provider.
Please call [site:phone] if you need further assistance completing this application.